Clinical Trial Update: Tranexamic Acid for The Management of Bleeding Gastrointestinal Angioectasias [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating tranexamic acid for bleeding GI angioectasias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Gastrointestinal Angioectasia
• Small Bowel Bleeding

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Anemia, Small Bowel Bleeding | Phase 2, Phase 3 | Status: COMPLETED